Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 5
Submit an article Journal homepage
60
Views
35
CrossRef citations to date
0
Altmetric
Research Article

Prophylaxis with Lamivudine of Hepatitis B Virus Reactivation in Chronic HbsAg Carriers with Hemato-oncological Neoplasias Treated with Chemotherapy

Giuseppe Rossi Sezione Ematologia, Dipartimento di Medicina, Spedali Civili, Brescia, Italy
Pages 759-766 | Published online: 01 Jul 2009

  • Maddrey, W.C. (2000) "Hepatitis B: an important public health issue", Journal of Medical Virology 61, 362-366.
  • Lee, W.M. (1997) "Hepatitis B virus infection", New England Journal of Medicine 337, 1733-1745.
  • Galbraith, R.M., Eddleston, A.L., Williams, R. and Zuckerman, A.J. (1975) "Fulminant hepatic failure in leukaemia and chloriocarcinoma related to withdrawal of cytotoxic drug therapy", Lancet 7934, 528-530.
  • Wands, J.R. (1975) "Subacute and chronic active hepatitis after withdrawal of chemotherapy", Lancet 7942, 979.
  • Hoofnagle, J.H., Dusheiko, G.M., Schafer. D.F., Jones, E.A., Micetich, K.C., Young, R.C. and Costa, J. (1982) "Reactivation of chronic hepatitis B virus infection by cancer chemotherapy", Annals of Internal Medicine 96, 447-449.
  • Thung, S.N., Gerber, M.A., Klion, F. and Gilbert. H. (1985) "Massive hepatic necrosis after chemotherapy withdrawal in a hepatitis B virus carrier", Archives of Internal Medicine 145, 1313-1314.
  • Bird, G.L., Smith, H., Portmann, B., Alexander, G.J. and Williams, R. (1989) "Acute liver decompensation on withdrawal of cytotoxic chemotherapy and immunosuppressive therapy in hepatitis B carriers", Quartely Journal of Medicine 73, 895-902.
  • Lau, J.Y., Lai, CL., Lin, H.J., Lok, A.S., Liang, R.H., Wu, P.C., Chan, T.K. and Todd, D. (1989) "Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients", Quarterly Journal of Medicine 73. 911 917.
  • Kawatani, T., Suou, T., Tajima, F. Ishiga, K., Omura, H., Endo, A., Ohmura, H., Ikuta, Y., ldobe, Y. and Kawasaki, H. (2001) "Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies", European Journal of Haematology 67, 45-50.
  • Obtsu, T., Sai, T., Oka, M., Sugai, Y and Tobinai, K. (1991) "Activation of hepatitis B virus infection by chemotherapy containing glucocorticoid in hepatitis B virus carriers with hematologie malignancies", Japanese Journal of Clinical Oncology 21, 360-365.
  • Markovic, S., Drozina, G., Vovk, M. and Fidler-Jenko, M. (1999) "Reactivation of hepatitis B but not hepatitis C in patients with malignant lymphoma and immunosuppressive therapy. A prospective study in 305 patients", Hepatogastroenterology 46, 2925-2930.
  • Persico, M., De Marino, F., Russo, G.D., Morante, A., Rotoli, B., Torella, R. and De Renzo, A. (2002) "Efficacy of lamivudine to prevent hepatitis reactivation in hepatitis B virus-infected patients treated for non-Hodgkin lymphoma", Blood 99, 724-725.
  • Kumagai, K., Takagi, T., Nakamura, S., Sawada, U., Kura, Y, Kodama, F., Shimano, S., Kudob, I., Nakamura, H., Sawada, K. and Ohnoshi, T. (1997) "Hepatitis B virus carriers in the treatment of malignant lymphoma: an epidemiological study in Japan", Annals of Oncology 8(Suppl. 1), 107-109.
  • Yeo, W., Chan, P.K., Zhong, S., Ho, W.M., Steinberg. J.L., Tam. J.S., Hui. P., Leung, N.W., Zee. B. and Johnson, P.J. (2000) "Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy a prospective study of 626 patients with identification of risk factors", Journal of Medical Virology 62, 299-307.
  • Liao, C.A., Lee, C.M., Wu, H.C., Wang, M.C., Lu, S.N. and Eng, H.L. (2002) "Lamivudine for the treatment of hepatitis B virus reactivation following chemotherapy for non-Hodgkin's lymphoma", British Journal of Haematology 116, 166-169.
  • Liang, R., Lau, G.K. and Kwong, Y.L. (1999) "Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem", Journal of Clinical Oncology 17, 394-398.
  • Lok, A.S., Linng, R.H., Chiu, E.K., Wong, K.L., Chan, T.K. and Todd, D. (1991) "Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study", Gastroenterology 100, 182-188.
  • Lau, O.K., Leung, Y.H., Fong, D.Y., Au, W.Y., Kwong, Y.L., Lie. A., Hou, J.L., Wen, Y.M., Nanj, A. and Liang, R. (2002) "High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation", Blood 99, 2324-2330.
  • Alexopoulos, C.G., Vaslamatzis, M. and Hatzidimitriou, G. (1999) "Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid rumours", British Journal of Cancer 81, 69-74.
  • Yeo, W., Chan, P.K., Chan, H.L., Mo, F.K. and Johnson, P.J. (2001) "Hepatitis B virus reactivation during cytotoxic chemotherapyenhanced viral replication precedes overt hepatitis", Journal of Medical Virology 65, 473-477.
  • Nakamura, Y., Motokura, T., Fujita, A., Yamashita, T. and Ogata, E. (1996) "Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies. Survey in Japan. 1987-1991", Cancer 78, 2210-2215.
  • Lau, O.K., Liang, R., Chiu, E.K., Lee, C.K. and Lam, S.K. (1997) "Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case controlled study", Bone Marrow Transplantation 19, 795-799.
  • Al-Taie,O.H.,Mork, H., Gassel, A.M., Wilhelm, M., Weissbrich, B. and Scheurlen, M. (1999) "Prevention of hepatitis B flare-up during chemotherapy using lamivudine: case report and review of the literature", Annals of Hematology 78, 247-249.
  • Silvestri, F., Ermacora, A., Sperotto, A., Patriarca, F. Zaja, F., Damiani, D., Fanin, R. and Baccarani, M. (2000) "Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivation", British Journal of Haematology 108, 394-396.
  • Ustun, C., Koc, H., Karayalcin, S., Akyol, O., Gurman, G., Ilhan, O., Akan, H., Ozcan, M., Arslan, O., Konuk, N., Uysal, A. and Beksac, M. (1997) "Hepatitis B virus infection in allogeneic bone marrow transplantation", Bone Marrow Transplantation 20. 289-296.
  • Chen, P.M., Chiou, T.J., Fan, F.S., Liu, J.M., Hsich, R.K., Yen, C.C., Wang, W.S. and Liu, J.H (2002a) "Fulminant hepatitis is significantly increased inhepatitis B carriers after allogeneic bone marrow transplantation", Transplantation 67, 1425-1433.
  • Cheng, A.L. (1996) "Steroid-free chemotherapy decreases the risk of hepatitis flare-up in hepatitis B virus carriers with non-Hodgkin's lymphoma", Blood 87, 1202.
  • Rossi, G., Pelizzari, A., Motta, M. and Puoti, M. (2001) "Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy", British Journal of Haematalogy 115, 58-62.
  • Chisari, F.V., Filippi, P., Buras, J., McLachlan, A., Popper. H., Pinkert, C.A., Palmiter, R.D. and Brinster, R.L. (1987) "Structural and pathological effects of synthesis of hepatitis B virus large envelope polypepnde in transgenic mice", Proceedings of the National Academy of Sciences USA 84, 6909-6913.
  • Roingeard, P., Romet-Lemonne, J.L., Leturcq, D., Goudeau, A. and Essex, M. (1990) "Hepatitis B virus core antigen (HBc Ag) accumulation in an HBV nonproducer clone of HepG2-transfected cells is associated with cytopathic effect", Virology 179, 113-120.
  • Martin, B.A., Rowe, J.M., Kouides, P.A. and DiPersio, J.F. (1995) "Hepatitis B reactivation following allogemc bone marrow transplabntalion. Case report and review of the literature", Bone Marrow Transplantation 15, 145-148.
  • McIvor, C., Morton, J., Bryant, A., Cooksley, W.G., Durrant, S. and Walker, N. (1994) "Fatal reactivation of precore mutant hepatitis B virus associated with fibrosing cholestatic hepatitis after bone marrow transplantation", Annals of Internal Medicine 121, 274-275.
  • Rehermann, B., Ferrari, C., Pasquinelli, C. and Chisari, F.V. (1996) "The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lyrnphocyle response", Nature Medicine 2, 1104-1108.
  • Steinberg, J.L., Yeo, W., Zhong, S., Chan, J.Y., Tarn, J.S., Chan, P.K., Leung, N.W. and Johnson, P.J. (2000) "Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role", Journal of Medical Virology 60, 249-255.
  • Tur-Kaspa, R., Shaul, Y., Moore, D.D., Burk, R.D., Okret, S., Poellinger, L. and Shafritz, D.A. (1988) "The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer", Virology 167, 630-633.
  • Hammond, A., Ramersdorfer, C. Palilzsch, K.D., Scholmerich, J. and Lock, G. (1999) "Fatal liver failure after corticosteroid treatment of a hepatitis B virus carrier", Deutsche Medizinische Wochenschrift 124, 687-690.
  • Yoshiba, M., Sekiyama, K., Sugata, K. Okamoto, H., Yamamoto, K. and Yotsumoto, S. (1992) "Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment", Digestive Disease Sciences 37. 1253-1259.
  • Carman, W.F., Jaeyna, M.R., Hadziyannis, S., Karayiannis, P., McGarvey, MJ., Makris, A. and Thomas, H.C. (1989) "Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection", Lancet 2, 588-591.
  • Kosaka, Y., Takase, K., Kojima, M., Shimizu, M., Inoue, K., Yoshiba, M., Tanaka, S., Akahane, Y., Okamoto, H. and Tsuda, F. (1991) "Fulminant hepatitis B: induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen", Gastroenterology 100, 1087-1094.
  • Yeo, W., Zhong, S., Chan, P.K., Ho, W.M., Wong, H.T., Chan, A.S. and Johnson, P.J. (2000) "Sequence variations of precore/core and precore promoter regions of hepatitis B virus in patients with or without viral reactivation during cytotoxic chemotherapy", Journal of Viral Hepatology 7, 448-458.
  • Dai, M.S., Lu, J.J.,' Chen, Y.C., Perng, C.L. and Chao, T.Y. (2001) "Reactivation of precore mutant hepatitis B virus in chemotherapy-treated patients", Cancer 92, 2927-2932.
  • Lau, J.Y., Bird, G.L., Gimson, A.E., Alexander, G.J. and Williams. R. (1991) 'Treatment of HBV reactivation after withdrawal of immunosuppression", Lancet 337, 802.
  • ter Borg, F, Smorenburg, S., de Man, R.A., Riebroek, R.C., Chamuleau, R.A. and Jones, E.A. (1998) "Recovery from lifethreatening, corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapy", Digestive Disease Sciences 43, 2267-2270.
  • Kumagai, K., Takagi, T. and Sakai, C. (1998) "Prevention of hepatitis development by interferon-alpha in HBV carriers treated with intensive chemotherapy: a pilot study", Annals of Oncology 9, 117-118.
  • Rizzetto, M., Volpes, R. and Smedile, A. (2000) "Response of precore mutant chronic hepatitis B infection to lamivudine", Journal of Medical Virology 61, 398-402.
  • Gish, R.G., Lau, J.Y., Brooks, L., Fang, J.W., Steady, L., Imperial. J.C., Garcia-Kennedy, R., Esquivel, C.O. and Keeffe, E.B. (1996) "Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients", Hepatology 23, 1-7.
  • [47) Mertens, T., Kock, J., Hampl, W., Schlicht, H.J., Tillmann, H.L., Oldhafer, K.J., Manns, M.P. and Arnold, R. (1996) "Reactivated fulminant hepatitis B virus replication after bone marrow transplantation: clinical course and possible treatment with ganciclovir", Journal of Hepalology 25, 968-971.
  • Lau, G.K., Liang, R., Wu, P.C., Lee, C.K., Lim, W.L. and Au, W.Y. (1998) "Use of famcielovir to prevent HBV reactivation in HBsAgpositive recipients after allogeneic bone marrow transplantation", Journal of Hepatology 28, 359-368.
  • Dienstag, J.L., Perrillo, R.P., Schiff, E.R., Bartholomew, M., Vicary, C. and Rubin, M. (1995) "A preliminary trial of lamivudine for chronic hepatitis B infection", New England Journal of Medicine 333, 1657-1661.
  • Schiff, E.R. (2000) "Response of pre-core mutant chronic hepatitis B infection to lamivudine", Journal of Medical Virology 61, 398-402.
  • Johnson, M.A., Moore, K.H., Yuen, G.J., Bye, A. and Pakes, G.E. (1999) "Clinical Pharmacokinetics of lamivuidine", Clinical Pharmacokineties 36, 41-66.
  • Lai, CL., Chien, R.N., Leung, N.W., Chang, T.T., Guan, R., Tai, D.I., Ng, K.Y., Wu, P.C., Dent, J.C., Barber, J., Stephenson, S.L., Gray, D.F. (1998) "A one-year trial of lamivudine tor chronic hepatitis B. Asia Hepatitis Lamivudine Study Group", New England Journal of Medicine 339, 61-68.
  • Jarvis, B. and Faulds, D. (1999) "Lamivudine, A review of its therapeutic potential in chronic hepatitis B", Drugs 58, 101-141.
  • Domsife, R.E. and Averett, D.R. (1996) "In vitro potency of inhibition by antiviral drugs of hematopoietie progenitor colony formation correlates with exposure at bemotoxic levels in human immunodeficiency virus-positive humans", Antimicrobial Agents and Chemotherapy 40, 514-519.
  • Clark, F.L., Drummond, M.W., Chambers, S., Chapman, B.A. and Parton, W.N. (1998) "Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin's lymphoma", Annals of Oncology 9, 385-387.
  • Picardi, M., Sellen, C., De Rosa, G., Raiola, A., Pezzullo, L. and Rotoli, B. (1998) "Lamivudine treatment for chronic replicative hepatitis B virus infection after allogeneic bone marrow transplantation", Bone Marrow Transplantation 21, 1267-1269.
  • Ahroed, A. and Keeffe, E.B. (1999) "Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection", American Journal of Gastroenterology 94, 249-251.
  • Maguire, C.M., Crawford, D.H., Hourigan, L.F., Clooston, A.D., Walpole, E.T. and Powell, E.E. (1999) "Case report: lamivudine therapy for submassive hepatic necrosis due to reactivation of hepatitis B following chemotherapy", Journal of Castroenterology and Hepatology 14, 801-803.
  • Kawai, Y., Ikegaya, S., Hata, M., Kawahito, M., Imamura, S., Yoshida, A., Tsutani, H. and Ueda, T. (2001) "Successful Lamivudine therapy for post-chemotherapeutic fulminant hepatitis B in a hepatitis B virus carrier with non-Hodgkin's lymphoma: case report and review of the literature", Annals of Hematology 80, 482-484.
  • Uchida, N., Gondo, H., Himeji, D., Kaji, Y., Sata, M. and Niho, Y. (2000) "Lamivudine therapy for a hepatitis B surface antigen (HBsAg)-posiüve leukemia patient receiving myeloablative chemotherapy and autologous stem cell transplantation", Bone Marrow Transplantation 26, 1243-1245.
  • Cainelli, F., Longhi, M.S., Concia, E. and Vento, S. (2001) "Failure of lamivudine therapy for chemotherapy-induced reactivation of hepatitis B", American Journal of Gastroenterology 96, 1651-1652.
  • Petrelli, E., Balducci, M., Pieretti, C., Rocchi, M.B., Clementi, M. and Manzin, A. (2001) "Lamivudine treatment failure in preventing fatal outcome of de nova severe acute hepatitis B in patients with haematological diseases", Journal of Hepatology 35, 823-826.
  • Yeo, W., Steinberg, J.L., Tam, J.S., Chan, P.K. Leung, N.W., Lam, K.C., Mok, T.S. and Johnson, P.J. (1999) "Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy", Journal of Medical Virology 59, 263-269.
  • Wong, W.W.S., Ma, M.M. and Bain, V.G. (1998) "Treatment of immunosuppression-related HBV exacerbation with lamivudine", Hepatology 28, 725A.
  • Lee, W.C., Wu, M.J., Cheng, C.H., Chen, C.H., Shu, K.H. and Lian, J.D. (2001) "Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients", American Journal of Kidney Disease 38. 1074-1081.
  • Liu, C.J., Lai, M.Y., Lee, P.H., Chou, N.K., Chu, S.H., Chen, PJ., Kao, J.H., Jen, YM. and Chen, D.S. (2001) "Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: a 4-year experience", Journal of Gastroenterology and Hepatology 16, 1001-1008.
  • Hamaki, T., Kami, M., Kasumi, E., Ueyama, J., Miyakoshi, S., Morinaga, S. and Mutou, Y. (2001) "Prophylaxis of hepatitis B reactivation using lamivudine in a patient receiving rituximab", American Journal of Hematology 68, 292-294.
  • Henkes, M., Martin, S., Einsele, H. and Aulitzky, W.E. (2002) "Successful antiviral treatment for fulminant reactivated hepatitis B after autologous stem cell transplantation and prophylaxis during subsequent allogeneic stem cell transplantation", Annals of Hematology 81, 343-346.
  • Nakagawa, M., Siraizu, Y. Suemura, M. and Sato, B. (2002) "Successful long-term control with lamivudine against reactivated hepatitis B infection following intensive chemotherapy and autologous peripheral blood stem cell transplantation in nonHodgkin's lymphoma: experience of 2 cases", American Journal of Hemalology 70, 60-63.
  • Endo, T., Sakai, T., Fajimoto, K., Yamamoto, S., Takashima, H., Haseyamo, Y, Nishio, M., Koizumi, K., Koike, T. and Sawada, K. (2001) "A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma", Bone Marrow Transplantation 27, 433-436.
  • Grellier, L, and Dusheiko, G.M. (1997) "Hepatitis B virus and liver transplantation: concepts in antiviral prophylaxis", Journal of Viral Hepatology 4(Suppl. 1). 111-116.
  • Strasser, S.I. and McDonald, G.B. (1999) "Hepatitis viruses and hematopietic cell transplantation: a guide to patient and donor management", Blood 93, 1127-1136.
  • Pelizzari, A.M., Motta, M. and Rossi, G. (2001) "Lamivudine as primary prophylaxis of chemotherapy-induced HBV reactivation in HBsAg-positive patients with hematologie malignancies", Haematologica 86(Suppl. to n10). 145.
  • Hamaki, T., Masahiro, K., Kusumi, K., Koichiro, Y. Ueyama, J., Miyakoshi, S., Morinaga, S. and Mutou, Y (2001) "A feasibility study of rituximab for patients with hepatitis B or C infection in the treatment of non-Hodgkin's lymphoma", Blood 98(Suppl. 2), 242b.
  • Shibolet, O., Dan, Y. Gillis, S., Hubert, A., Shouval, D. and Safadi, R. (2002) "Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers", Blood 100, 391-396.
  • Lau, G.K., He, M.L., Fong, D.Y, Bartholomeusz, A., Aum W.Y., Lie, A.K., Locarinini, S. and Liang, R. (2002) "Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantation", Hepatology 36, 702-709.
  • Tseng, A., Conly, J., Fletcher, D. Keystone, D., Salit, I. and Walmsley, S. (1998) "Precipitous declines in hemoglobin levels associated with combination zidovudine and lamivudine therapy", Clinical Infectious Disease 27, 908-909.
  • Hester, E.K. and Peacock, Jr., J.E. (1998) "Profound and unanticipated anemia with lamivudine-zidovudine combination therapy in zidovudine-experienced patients with HIV infection", AIDS 12, 439-440.
  • Majluf-Cruz, A., Luna-Castanos, G., Trevino-Perez, S., Santoscoy, M. and Nieto-Cisneros, L. (2000) "Lamivudine-induced pure red cell aplasia", American Journal of Hematology 65, 189-191.
  • Zoulim, E (2001) "Detection of hepatitis B virus resistance to antivirals", Journal of Clinical Virology 21, 243-253.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.